UHS Prices $1.1B Senior Secured Notes Offering, Upsized from $700M
UHS sits 21% above its 52-week low of $140.08.
Summary
UHS priced a $1.1 billion senior secured notes offering, upsized from the $700 million initially targeted, to refinance near-term maturities and bolster liquidity.
Key Events · Financing and Capital Events · UHS
-
$1.1B Notes Offering Priced
UHS priced $600M of 5.500% senior secured notes due 2031 at 99.937% and $500M of 6.000% notes due 2036 at 99.359%, upsized from the $700M refinancing target disclosed August 10.
-
Refinancing and Liquidity
Proceeds will refinance the $700 million senior secured notes maturing September 2026, with the balance available for general corporate purposes, extending the maturity profile and adding liquidity.
-
Investment-Grade Ratings
The notes are rated Baa3 by Moody's, BBB- by S&P and Fitch, reflecting stable credit quality despite recent operational challenges.
-
Pricing Context
The 2031 notes priced at a spread of +112.5 bps to the 4.375% UST due July 2031, and the 2036 notes at +140 bps to the 4.375% UST due May 2036, indicating strong institutional demand.
Analysis · UHS · Industrial Applications And Services
Universal Health Services locked in terms on a $1.1 billion two-tranche senior secured notes offering — $600 million of 5.500% notes due 2031 and $500 million of 6.000% notes due 2036. The deal was upsized from the $700 million refinancing target disclosed two days ago, signaling strong demand. Proceeds will refinance the $700 million maturity due September 2026, with the remainder likely for general corporate purposes. The notes carry investment-grade ratings (Baa3/BBB-/BBB-) and were priced at tight spreads to Treasuries, reflecting credit market confidence despite recent operational headwinds — including the behavioral health division leadership change, facility license losses, and lowered full-year guidance.
At the time of this filing, UHS was trading at $169.00 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $10.2B. The 52-week trading range was $140.08 to $246.33. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.